IN8bio Appoints Kenneth R. LaMontagne, Ph.D., to Lead Business Development
NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
News
Recce Pharmaceuticals Appoints Philip Sutton, Ph.D., as Vice President of Translational Sciences
– Dr. Sutton to help advance Recce’s portfolio of infectious disease programs focused on significant…
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III
ProKidney Class A ordinary shares to begin trading on Nasdaq under the ticker symbol “PROK”…
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022
WOBURN, Mass., July 12, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Quotient Limited and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu
Partnership aims to expand the Transfusion Transmissible Infections, other Infectious Diseases, and clinical diagnostics assay…
CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal
MONTREAL, July 12, 2022 (GLOBE NEWSWIRE) — CQDM, the Quebec Breast Cancer Foundation and Theratechnologies…
Dyne Therapeutics Announces Clearance of Clinical Trial Application for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1
– Initiation of Dosing in Multiple Ascending Dose Clinical Trial of DYNE-101 in Patients with…
Plus Therapeutics Successfully Completes Key Milestone for cGMP Manufacture of Lead Investigational Radiotherapeutic
Completes technology transfer and initiates cGMP manufacturing for critical Rhenium-186 NanoLiposome (186RNL) drug product intermediate…
Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products
Societal to Receive Greater Portion of Profit Sharing from Verapamil PM Product Sales Societal Awarded…
Rhythm Pharmaceuticals Announces Positive Interim Results from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity
–All evaluable patients (N=11) achieved BMI decrease of more than 5 percent at 16 weeks…
Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCs
SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (“Sutro” or…
Oncotelic Announces Presentation of P001- OT-101 Phase 1/2 Trial in Pancreatic Cancer
AGOURA HILLS, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology…
Introducing Welcome Unlimited. Verizon’s best unlimited price ever.
It’s easy to switch to the network more people rely on. In fact, keep your…
NavigateIO Graduates from NEC X Corporate Accelerator Program with First Responder Smart Tracking Technology
Award-winning localization technology speeds rescue time by 60% PALO ALTO, Calif. and PRINCETON, N.J., July…
AvePoint Strengthens Security and Streamlines IT Operations for the Modern Workplace
Company’s latest cloud platform release addresses growing demand for multi-SaaS solutions helping make businesses more…
Ascent Cloud Announces Launch of New Product: Territory Planner
Territory Planner by Ascent Cloud creates a flexible territory planning solution to build, balance and…
Tenable Introduces Nessus Expert with External Attack Surface Management and Cloud Security Capabilities
Provides complete visibility across modern attack surfaces COLUMBIA, Md., July 12, 2022 (GLOBE NEWSWIRE) —…
Phunware Announces Twitter Integration for Smart Advocacy Solution
AUSTIN, Texas, July 12, 2022 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a…